Home > Press > Global Crown Capital Announces Nanotechnology Index Quarterly Rebalance
Abstract:
(Bloomberg: GCCLGCNI)
Global Crown Capital Announces Nanotechnology Index Quarterly Rebalance
SAN FRANCISCO, CA | Posted on April 17th, 2008
The 1Q08 rebalancing of the Global Crown Capital Nanotechnology Index added five new stocks while removing four, increasing the total number of components in the index to 29. The five newly added components are Applera Corp. (ABI), Bruker Corp. (BRKR), CombiMatrix Corp. (CBMX), and Nanosphere, Inc. (NSPH). The components removed from the index no longer qualify, as they are trading below the $1.00 per share threshold. The removed components are Acusphere (ACUS), Immunicon Corp. (IMMC), Nanogen Inc. (NGEN), and Psvidia ADR (PSDV).
During 1Q08 the GCC Nanotechnology Index declined 6.5%, outperforming both NASDAQ-100 and S&P 500 indices by 6.6% and 2.1%, respectively. The best performing stock was Illumina (ILMN), moving up 28.1%. The worst performing stock was Altair Nanotechnologies (ALTI), dropping 37.6%. The average daily trading volume is over 500,000 shares and the total market cap of the index is over $32 billion.
The GCC Nanotechnology Index is designed to track the stock performance of the nanotechnology industry. Many companies are active in nanotechnology, but only those public companies whose stock performance GCC believes moves with the success or failure of its nanotechnology efforts are eligible for inclusion. Large multi-national corporations are often spending on nanotechnology research and have nanotechnology-enabled product lines, but if GCC believes their stock prices move mainly for reasons other than nanotechnology, they are not included. Similarly stocks which trade below $1.00 or are not on a national U.S. exchange are not eligible.
As the nanotechnology industry evolves, the list of the companies included in the GCC Nanotechnology Index changes. The number of components included in the index can increase or decrease depending on the number of U.S. public companies primarily focused on nanotechnology (IPO, mergers and acquisitions, or refocusing of business activities).
####
About Global Crown Capital, LLC
Global Crown Capital, LLC is a research-focused boutique investment firm broadly and deeply focused on technology. The firm specializes in Global Equity Research, Institutional Sales and Trading, Prime Brokerage, Global Wealth Management, Asset Management, Investment Banking and Corporate Services. GCC is a member of FINRA/NFA/SIPC.
For more information, please click here
Contacts:
Global Crown Capital, LLC
Helen Simms
415-354-7183
Copyright © Business Wire 2008
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Investments/IPO's/Splits
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013